Qiagen has announced the commercial launch in India of its careHPV test, the only molecular diagnostic for high-risk human papillomavirus (HPV) designed to screen women in settings with limited healthcare infrastructure, such as areas ...
Tags: CareHPV Test, Qiagen
BD Launches the PAXgene® Blood DNA Tube in Europe BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the commercial availability of the CE-marked PAXgene® Blood DNA Tube in Europe. The ...
Tags: BD, DNA, PAXgene, PreAnalytiX GmbH
Becton, Dickinson and Company (BD) has announced the commercial availability of its PAXgene blood DNA tube, a blood collection tube designed specifically for IVD genomic DNA testing, in Europe. Initial target customers for the CE-marked ...
Tags: BD, Qiagen, dna, PreAnalytiX
PrimeraDx, a molecular diagnostics company, has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its ICEPlex C. difficile assay kit and the ICEPlex system. The ICEPlex system is a multiplex real-time PCR system ...
Myriad Genetics, a molecular diagnostic company, and biotechnology firm BioMarin Pharmaceutical have signed a research collaboration agreement for identifying tumor types that may be sensitive to BioMarin's investigational product ...
Tags: Myriad Genetics, Biomarin
US-based Illumina has obtained premarket clearance from the US Food and Drug Administration (FDA) for the MiSeqDx system, a high-throughput DNA sequencing analyzer. The company has also obtained premarket clearance from the FDA for the ...
Tags: Illumina, MiSeqDx System
Hologic, a manufacturer of diagnostic and medical imaging systems, has obtained Health Canada approval for its Aptima HPV assay for use on the company's fully automated Panther system. Aptima HPV assay has been designed to detect ...
Tags: Health Canada, Aptima HPV Assay
NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has announced the availability of the nCounter Dx analysis system for high-complexity, CLIA-certified laboratories. ...
Tags: NanoString, DX Analysis System
Transgenomic, a global biotechnology company, and US-based PerkinElmer have entered into a collaboration agreement for marketing and distributing Transgenomic’s line of molecular diagnostic oncology products in territories outside the ...
Myriad Genetics, a US-based molecular diagnostic company, has launched a new prognostic test, Myriad myPlan Lung Cancer, for patients diagnosed with early-stage lung adenocarcinoma. myPlan lung cancer test is an RNA expression panel of 31 ...
Global biotechnology company Transgenomic has signed a collaboration agreement with PDI, a health care commercialization company, to commercialize its CardioPredict. Developed by Transgenomic, CardioPredict identifies a patient's specific ...
Medical device company Aethlon Medical has launched a new subsidiary Exosome Sciences to pursue exosome-based strategies for diagnosing and monitoring the progression of cancer, infectious disease and other life-threatening conditions. ...
Tags: Medical device, Aethlon Medical
IntelligentMDx (IMDx) has received the US Food and Drug Administration (FDA) approval for its second automated molecular diagnostic test for use on Abbott's fully automated m2000 platform. The automated molecular diagnostic test detects ...
NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has obtained the US Food and Drug Administration (FDA) 510(k) clearance for its Prosigna breast cancer prognostic gene ...
Molecular diagnostic company Myriad Genetics has launched myRisk Hereditary Cancer, a new multi-gene diagnostic test for hereditary cancer testing. The new test analyses 25 genes that are associated with breast, colorectal, ovarian, ...
Tags: Multi-Gene Test, Medicine